Vaccination Coverage Against Coronavirus Disease 2019 (COVID-19) in Brazil’s Indigenous Population.

Publication date: May 01, 2026

Indigenous populations in Brazil were prioritized for coronavirus disease 2019 (COVID-19) vaccination due to their increased vulnerability. The aim of the study was to describe COVID-19 vaccination coverage among Indigenous population across Brazilian regions and Special Indigenous Health Districts (DSEIs; acronym for Distritos SanitcE1rios Especiais IndcEDgenas). A retrospective study was conducted using data from January 17, 2021, to June 27, 2024, obtained from the open-access COVID-19 vaccination database made available by the Brazilian Ministry of Health, covering the 4-year period of the pandemic. The dataset included information on the Indigenous population (number of inhabitants), as well as the number and type of vaccine doses administered (first dose, second dose, single dose, and booster dose). Second dose refers to vaccines requiring a two-dose primary schedule, whereas single-dose refers to vaccines administered as a single primary dose; booster dose refers to any additional dose given after completion of the primary vaccination schedule and, according to the database, was restricted to individuals aged ≥ 18 years. Vaccination coverage was calculated by dividing the number of doses administered by the total Indigenous population, based on estimated from the 2022 Brazilian Institute of Geography and Statistics (IBGE; acronym for Instituto Brasileiro de Geografia e EstatcEDstica) Census, and multiplying by 100. The data was analyzed and presented according to Brazil’s federative units (states and the Federal District) and DSEIs. A total of 1 490 036 COVID-19 vaccine doses were administered to the Indigenous population. Of these, 631 990 (42%) corresponded to first doses, 551 602 (27%) to second or single doses, and 306 444 (21%) to booster doses. These doses corresponded to vaccination coverage of 89%, 78%, and 43% of the Indigenous population (N = 707 739), respectively. Across the 27 federative units, the lowest coverage for the first dose was observed in Tocantins (83%), Roraima (74%), and ParcE1 (73%), while for second or single doses the lowest rates were found in AmapcE1 (63%), Roraima (60%), and ParcE1 (58%). Among the 34 DSEIs, 13 (38. 2%) did not reach 90% coverage for the first dose, and 21 (61. 8%) did not reach this threshold for the second or single doses. The lowest coverage levels were identified in Araguaia (65% and 44%), Rio TapajcF3s (59% and 40%), and KaiapcF3 do ParcE1 (56% and 34%) for first and second or single doses, respectively. Vaccination coverage against COVID-19 among Brazil’s Indigenous population has not fully reached the 90% target recommended by the Brazilian government in alignment with the World Health Organization after 4 years of the pandemic. This gap may be explained by multiple factors, including cultural barriers, remote geographic conditions, and logistical challenges related to vaccine distribution.

Open Access PDF

Concepts Keywords
Brazil Adolescent
Coronavirus Adult
June Aged
Brazil
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
epidemiology
Female
Humans
Immunization Schedule
Indigenous
Male
Middle Aged
pandemic
public health
Retrospective Studies
SARS-CoV-2
SARS‐CoV‐2
Vaccination
Vaccination Coverage
vaccines
vulnerable population
Young Adult

Semantics

Type Source Name
disease MESH Coronavirus Disease 2019
disease MESH included
drug DRUGBANK Ribostamycin
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
drug DRUGBANK Tretamine
disease MESH face
disease MESH malnutrition
disease MESH respiratory diseases
disease MESH influenza
disease MESH emergency
disease MESH malaria
pathway KEGG Malaria
disease MESH sexually transmitted infections
drug DRUGBANK BCG vaccine
disease MESH dis
disease MESH severe acute respiratory syndrome
disease MESH infection
drug DRUGBANK Spinosad
disease MESH fed
drug DRUGBANK Oxygen
disease MESH death
disease MESH obesity
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Trestolone
disease MESH cam
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Cysteamine
disease MESH fac
drug DRUGBANK Serine
disease MESH Plan
pathway REACTOME Translation
disease MESH CoInfections
drug DRUGBANK Gold
disease MESH Dengue
disease MESH Poliomyelitis
disease MESH Hos
drug DRUGBANK Adenosine 5′-phosphosulfate
drug DRUGBANK Medical air

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *